Cabometyx 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FX2GD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,483
Award facts
- Contract value 100% obligated
- $16,483.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count packages) on September 29, 2025, with an ultimate completion date of September 30, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being performed at the contractor's location in Park Ridge, Illinois. Cabometyx, an oncology medication, is being supplied to support the pharmaceutical needs of military health facilities as part of the federal government's healthcare supply chain.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that authorizes the issuance of firm fixed-price orders for a comprehensive range of pharmaceutical products. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, has established itself as a critical supplier in the federal pharmaceutical supply chain, providing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites nationwide. The company's selection demonstrates its capability to reliably deliver specialized pharmaceutical products to support military medical operations globally.
Quick answers
Who was awarded contract SPE2DB25FX2GD?
SPE2DB25FX2GD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FX2GD worth?
The government has obligated $16,483 on SPE2DB25FX2GD.
Is contract SPE2DB25FX2GD an order under another contract?
Yes. SPE2DB25FX2GD is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2GD competed?
The extent of competition for SPE2DB25FX2GD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award